La imagen puede variar dependiendo del país en el que se comercialice.
Laboratorio fabricante
CZ Vaccines S.A.U.
Medicamento sujeto a prescripción veterinaria
B-19 CZV OCULAR
Ocular vaccine against Brucella abortus, the causative agent of bovine brucellosis. Powder and solvent for suspension
Composición
Each dose (approx. 35 μl) of reconstituted vaccine contains:
Active sustrongstance:
Live attenuated Brucella abortus, strain B-19 (smooth phase) 4-7 x 109 ufc*
Excipients:
Active sustrongstance:
Live attenuated Brucella abortus, strain B-19 (smooth phase) 4-7 x 109 ufc*
*CFU: colony forming units
Excipients:
Patent Blue V (E-131) 0,01%
Indicaciones
For the active immunisation of cattle against brucellosis caused byB. abortusorB. melitensis to prevent infection.
Onset of immunity: 4 weeks.
Onset of immunity: 4 weeks.
Vía de administración
Ophthalmic.
Posología
A single dose (1 drop) for female cattle older than 3 months. In areas of high prevalence, animals may be revaccinated 2 months after the initial dose.
For vaccination combined with a test and cull programme, use is restricted to young replacement females between 3 and 5 months of age. In areas of low prevalence, a single vaccine dose is sufficient. In areas of high prevalence, revaccination is advised 2 months after the first dose.
For vaccination combined with a test and cull programme, use is restricted to young replacement females between 3 and 5 months of age. In areas of low prevalence, a single vaccine dose is sufficient. In areas of high prevalence, revaccination is advised 2 months after the first dose.
Pauta de vacunación
Tiempo de espera
Zero days.
